相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Potent antitumor activity of the anti-CD19 auristatin antibody drug conjugate hBU12-vcMMAE against rituximab-sensitive and -resistant lymphomas
Hans-Peter Gerber et al.
BLOOD (2009)
The impact of Fc engineering on an anti-CD19 antibody: increased Fcγ receptor affinity enhances B-cell clearing in nonhuman primates
Jonathan Zalevsky et al.
BLOOD (2009)
Lenalidomide down-regulates the CD20 antigen and antagonizes direct and antibody-dependent cellular cytotoxicity of rituximab on primary chronic lymphocytic leukemia cells
Rosa Lapalombella et al.
BLOOD (2008)
Colocalization of the IL-12 receptor and FcγRIIIa to natural killer cell lipid rafts leads to activation of ERK and enhanced production of interferon-γ
Sri Vidya Kondadasula et al.
BLOOD (2008)
Potent in vitro and in vivo activity of an Fc-engineered anti-CD19 monoclonal antibody against lymphoma and leukemia
Holly M. Horton et al.
CANCER RESEARCH (2008)
Lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells.
Lei Wu et al.
CLINICAL CANCER RESEARCH (2008)
Alemtuzumab compared with chlorambucil as first-line therapy for chronic lymphocytic leukemia
Peter Hillmen et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Targeting CD37-positive lymphoid malignancies with a novel engineered small modular immunopharmaceutical
Xiaobin Zhao et al.
BLOOD (2007)
Targeted therapies for non-hodgkin lymphoma: Rationally designed combinations
Peter Martin et al.
CLINICAL LYMPHOMA & MYELOMA (2007)
Phase 1 study of lumiliximab with detailed pharmacokinetic and pharmacodynamic measurements in patients with relapsed or refractory chronic lymphocytic leukemia
John C. Byrd et al.
CLINICAL CANCER RESEARCH (2007)
MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment
Juergen Bernhagen et al.
NATURE MEDICINE (2007)
Fc gamma R: The key to optimize therapeutic antibodies?
Sophie Siberil et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2007)
FcγRIII engagement provides activating signals to NKT cells in antibody-induced joint inflammation
Hye Young Kim et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Engineered antibody Fc variants with enhanced effector function
GA Lazar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Alemtuzumab induces caspase-independent cell death in human chronic lymphocytic leukemia cells through a lipid raft-dependent mechanism
AP Mone et al.
LEUKEMIA (2006)
CD56dimCD16neg cells are responsible for natural cytotoxicity against tumor targets
O Penack et al.
LEUKEMIA (2005)
Proapoptotic activity of alemtuzumab alone and in combination with rituximab or purine nucleoside analogues in chronic lymphocytic leukemia cells
P Smolewski et al.
LEUKEMIA & LYMPHOMA (2005)
Hu1D10 induces apoptosis concurrent with activation of the AKT survival pathway in human chronic lymphocytic leukemia cells
AP Mone et al.
BLOOD (2004)
Rituximab and alemtuzumab induce a nonclassic, caspase-independent apoptotic pathway in B-lymphoid cell lines and in chronic lymphocytic leukemia cells
M Stanglmaier et al.
ANNALS OF HEMATOLOGY (2004)
Urokinase-type plasminogen activator receptor crosslinking in an NK cell line increases integrin surface expression by the MAP kinase/ERK 1/2 signaling pathway
GC Gellert et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
IL-12 enhances the natural killer cell cytokine response to Ab-coated tumor cells
R Parihar et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
The chimeric anti-CD20 antibody rituximab induces apoptosis in B-cell chronic lymphocytic leukemia cells through a p38 mitogen activated protein-kinase-dependent mechanism
IM Pedersen et al.
BLOOD (2002)
Morphologically typical and atypical B-cell chronic lymphocytic leukemias display a different pattern of surface antigenic density
G D'Arena et al.
LEUKEMIA & LYMPHOMA (2001)
CD19 regulates intrinsic B lymphocyte signal transduction and activation through a novel mechanism of processive amplification
M Fujimoto et al.
IMMUNOLOGIC RESEARCH (2000)
分享论文
